.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Moodys
Federal Trade Commission
Citi
Cerilliant
Boehringer Ingelheim
Queensland Health
Deloitte
Daiichi Sankyo
US Army

Generated: November 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 208692

« Back to Dashboard
NDA 208692 describes CABOMETYX, which is a drug marketed by Exelixis Inc and is included in one NDA. It is available from one supplier. There are four patents protecting this drug. Additional details are available on the CABOMETYX profile page.

The generic ingredient in CABOMETYX is cabozantinib s-malate. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the cabozantinib s-malate profile page.

Summary for 208692

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:4

Pharmacology for NDA: 208692

Mechanism of ActionProtein Kinase Inhibitors

Suppliers and Packaging for NDA: 208692

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CABOMETYX
cabozantinib s-malate
TABLET;ORAL 208692 NDA Exelixis, Inc. 42388-023 42388-023-26 30 TABLET in 1 BOTTLE (42388-023-26)
CABOMETYX
cabozantinib s-malate
TABLET;ORAL 208692 NDA Exelixis, Inc. 42388-024 42388-024-26 30 TABLET in 1 BOTTLE (42388-024-26)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 20MG BASE
Approval Date:Apr 25, 2016TE:RLD:Yes
Regulatory Exclusivity Expiration:Nov 29, 2017
Regulatory Exclusivity Use:NEW CHEMICAL ENTITY
Regulatory Exclusivity Expiration:Apr 25, 2019
Regulatory Exclusivity Use:NEW PRODUCT
Patent:► SubscribePatent Expiration:Aug 14, 2026Product Flag?YSubstance Flag?YDelist Request?


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Chinese Patent Office
Boehringer Ingelheim
Johnson and Johnson
Medtronic
Argus Health
Chubb
McKinsey
Farmers Insurance
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot